American Society for Reproductive Medicine
Impacting Reproductive Care Worldwide
American Society for Reproductive Medicine
EIN: 04-2284338
as of November 2023
as of November 13, 2023
Programs and results
Reports and documents
Download annual reportsWhat we aim to solve
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
ASRM Research Institute
The ASRM Research Institute focuses on areas that will have the most impact on the practice of reproductive medicine, particularly when other funding sources are inadequate. Funding from the institute will allow current researchers and the next generation of researchers to explore relevant topics, such as basic human gametes and embryos, the human trophectoderm, the role of precision medicine in reproductive care, and access to care.
Where we work
External reviews

Our Sustainable Development Goals
Learn more about Sustainable Development Goals.
Goals & Strategy
Reports and documents
Download strategic planLearn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
The American Society for Reproductive Medicine (ASRM) is dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in evidence-based, life-long education and learning, through the advancement and support of innovative research, through the development and dissemination of the highest ethical and quality standards in patient care, and through advocacy on behalf of physicians and affiliated healthcare providers and their patients.
What are the organization's key strategies for making this happen?
What are the organization's capabilities for doing this?
What have they accomplished so far and what's next?
Financials
Financial documents
Download audited financialsRevenue vs. expenses: breakdown
Liquidity in 2022 info
8.53
Months of cash in 2022 info
4
Fringe rate in 2022 info
27%
Funding sources info
Assets & liabilities info
Financial data
American Society for Reproductive Medicine
Revenue & expensesFiscal Year: Jul 01 - Jun 30
American Society for Reproductive Medicine
Balance sheetFiscal Year: Jul 01 - Jun 30
The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.
Fiscal Year: Jul 01 - Jun 30
This snapshot of American Society for Reproductive Medicine’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.
Created in partnership with
Business model indicators
Profitability info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Unrestricted surplus (deficit) before depreciation | $2,894,469 | $2,794,718 | $1,089,029 | $7,932,610 | -$7,794,298 |
As % of expenses | 26.5% | 24.1% | 9.2% | 89.4% | -69.2% |
Unrestricted surplus (deficit) after depreciation | $2,549,926 | $2,421,347 | $673,071 | $7,630,220 | -$7,979,590 |
As % of expenses | 22.6% | 20.3% | 5.5% | 83.2% | -69.7% |
Revenue composition info | |||||
---|---|---|---|---|---|
Total revenue (unrestricted & restricted) | $11,829,601 | $15,321,620 | $15,017,121 | $11,441,954 | $12,105,861 |
Total revenue, % change over prior year | -4.6% | 29.5% | -2.0% | -23.8% | 5.8% |
Program services revenue | 82.1% | 64.6% | 71.1% | 48.1% | 63.3% |
Membership dues | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Investment income | 11.2% | 7.6% | 9.5% | 12.1% | 12.6% |
Government grants | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
All other grants and contributions | 5.5% | 8.9% | 11.1% | 11.4% | 12.0% |
Other revenue | 1.2% | 18.9% | 8.3% | 28.4% | 12.1% |
Expense composition info | |||||
---|---|---|---|---|---|
Total expenses before depreciation | $10,919,874 | $11,583,648 | $11,882,587 | $8,870,429 | $11,259,987 |
Total expenses, % change over prior year | 5.0% | 6.1% | 2.6% | -25.3% | 26.9% |
Personnel | 36.5% | 34.1% | 34.7% | 49.2% | 40.8% |
Professional fees | 2.6% | 2.2% | 3.9% | 4.3% | 6.5% |
Occupancy | 3.4% | 3.0% | 3.6% | 4.0% | 4.2% |
Interest | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Pass-through | 3.8% | 8.8% | 14.7% | 18.4% | 10.3% |
All other expenses | 53.7% | 51.8% | 43.0% | 24.1% | 38.2% |
Full cost components (estimated) info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Total expenses (after depreciation) | $11,264,417 | $11,957,019 | $12,298,545 | $9,172,819 | $11,445,279 |
One month of savings | $909,990 | $965,304 | $990,216 | $739,202 | $938,332 |
Debt principal payment | $0 | $0 | $0 | $0 | $78,489 |
Fixed asset additions | $0 | $0 | $0 | $1,908,390 | $0 |
Total full costs (estimated) | $12,174,407 | $12,922,323 | $13,288,761 | $11,820,411 | $12,462,100 |
Capital structure indicators
Liquidity info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Months of cash | 1.8 | 2.5 | 3.4 | 6.7 | 4.0 |
Months of cash and investments | 59.6 | 59.9 | 62.6 | 101.3 | 68.1 |
Months of estimated liquid unrestricted net assets | 49.5 | 49.5 | 49.3 | 76.0 | 51.5 |
Balance sheet composition info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Cash | $1,608,667 | $2,366,289 | $3,320,888 | $4,921,794 | $3,797,343 |
Investments | $52,639,068 | $55,497,339 | $58,651,361 | $69,942,182 | $60,132,019 |
Receivables | $1,750,685 | $1,593,285 | $2,381,229 | $1,786,177 | $1,797,258 |
Gross land, buildings, equipment (LBE) | $4,740,728 | $4,758,110 | $4,893,699 | $6,797,345 | $6,938,691 |
Accumulated depreciation (as a % of LBE) | 65.2% | 72.8% | 79.3% | 61.5% | 64.5% |
Liabilities (as a % of assets) | 8.1% | 8.6% | 9.1% | 8.8% | 11.0% |
Unrestricted net assets | $46,699,796 | $49,121,143 | $49,794,214 | $57,424,434 | $49,444,844 |
Temporarily restricted net assets | $4,216,040 | $4,692,252 | N/A | N/A | N/A |
Permanently restricted net assets | $3,540,360 | $3,495,360 | N/A | N/A | N/A |
Total restricted net assets | $7,756,400 | $8,187,612 | $11,242,281 | $16,728,315 | $13,066,093 |
Total net assets | $54,456,196 | $57,308,755 | $61,036,495 | $74,152,749 | $62,510,937 |
Key data checks
Key data checks info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Material data errors | No | No | No | No | No |
Operations
The people, governance practices, and partners that make the organization tick.
Documents
Executive Director
Dr. Jared C. Robins
Dr. Robins has an undergraduate degree from Emory University and obtained his MD from the State University of New York Stony Brook. Following an OB/GYN residency at Albert Einstein College of Medicine he did his fellowship in Reproductive Endocrinology and Infertility at the University of Cincinnati. He also has an MBA from the Kellogg School of Management at Northwestern University. Dr. Robins is currently the Executive Director of the American Society for Reproductive Medicine. Prior to joining the ASRM, Dr. Robins has served as a faculty member at the University of Cincinnati, Brown University and Northwestern University, where he served as Chief of the Division of Reproductive Endocrinology and Infertility, and as Director of International Medicine. Dr Robins has long been a member of ASRM and the Society for Reproductive Endocrinology and Infertility, where he served as Education Committee Chair and Secretary Treasurer. He has been an Editorial Board member for the F&S Journal.
Number of employees
Source: IRS Form 990
American Society for Reproductive Medicine
Officers, directors, trustees, and key employeesSOURCE: IRS Form 990
Compensation data
American Society for Reproductive Medicine
Highest paid employeesSOURCE: IRS Form 990
Compensation data
American Society for Reproductive Medicine
Board of directorsas of 06/07/2023
Board of directors data
Dr. Michael Thomas
University of Cincinnati
Term: 2022 - 2023
Marcelle I Cedars
University of Californai San Francisco
Michael A Thomas
University of Cincinnati
Jim P Toner
Emory Reproductive Center
Amy E Sparks
Center for Advanced Reproductive Care
Alan S Penzias
Boston IVF
Lauri A Pasch
University of California San Francisco
Brad J Milette
Dominion Fertility
Ruben J Alvero
Women and Infants Hospital of Rhode Island
Paula Amato
Oregon Health & Sciences University
Elizabeth Ginsburg
Brigham & Women's Hospital
Hugh S. Taylor
Yale University
Akanksha Mehta
Emory University
Kim L. Thornton
Boston IVF
Eve Feinberg
Northwestern University
Sangita Jindal
Montefiore Institute for Reproductive Medicine and Health
James F. Smith
UCSF
Steven L. Young
Duke University
John Preston Parry
Positive Steps Fertility
Organizational demographics
Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.
Leadership
The organization's leader identifies as:
Race & ethnicity
No data
Gender identity
No data
No data
Sexual orientation
No data
Disability
No data